Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Harbaum

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Pneumologie (Stuttgart, Germany)|September 14, 2022
[Intimal pulmonary sarcoma: A case report of a rare differential diagnosis of chronic thromboembolic pulmonary hypertension]Julian Pott, Paulina Gräfin Zu Reventlow, Marcel Simon, et al.
Histopathology|February 22, 2012
Mucinous differentiation in colorectal cancer--indicator of poor prognosis?Cord Langner, Lars Harbaum, Marion J Pollheimer, et al.
Plos One|April 23, 2014
N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiencyLars Harbaum, Jan K Hennigs, Hans J Baumann, et al.
ERJ Open Research|March 16, 2023
Clinical phenotyping of plasma thrombospondin-2 reveals relationship to right ventricular structure and function in pulmonary hypertensionAnna M Dittrich, Julia Mienert, Julian Pott, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 11, 2010
Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastasesLars Harbaum, Marion J Pollheimer, Thomas Bauernhofer, et al.
Chronic Respiratory Disease|September 10, 2025
Telomere biology disorder associated lung disease- case report of a <i>TERT</i> gene variant as the cause of pleuroparenchymal fibroelastosisJulian Pott, Ann-Sophie Höing, Alexander Volk, et al.
Lung|May 1, 2015
Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial HypertensionJasmin Wellbrock, Lars Harbaum, Hauke Stamm, et al.
Virchows Archiv : an International Journal of Pathology|June 15, 2016
MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significanceJohannes Betge, Nora I Schneider, Lars Harbaum, et al.
BMC Pulmonary Medicine|April 28, 2017
Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertensionLars Harbaum, Kaaja M Baaske, Marcel Simon, et al.
Pneumologie (Stuttgart, Germany)|November 14, 2023
[Targeted therapy for pulmonary arterial hypertension in patients without comorbidities]Hans Klose, Lars Harbaum, Manuel J Richter, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Pneumologie (Stuttgart, Germany)|September 14, 2022
[Intimal pulmonary sarcoma: A case report of a rare differential diagnosis of chronic thromboembolic pulmonary hypertension]Julian Pott, Paulina Gräfin Zu Reventlow, Marcel Simon, et al.
Histopathology|February 22, 2012
Mucinous differentiation in colorectal cancer--indicator of poor prognosis?Cord Langner, Lars Harbaum, Marion J Pollheimer, et al.
Plos One|April 23, 2014
N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiencyLars Harbaum, Jan K Hennigs, Hans J Baumann, et al.
ERJ Open Research|March 16, 2023
Clinical phenotyping of plasma thrombospondin-2 reveals relationship to right ventricular structure and function in pulmonary hypertensionAnna M Dittrich, Julia Mienert, Julian Pott, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 11, 2010
Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastasesLars Harbaum, Marion J Pollheimer, Thomas Bauernhofer, et al.
Chronic Respiratory Disease|September 10, 2025
Telomere biology disorder associated lung disease- case report of a <i>TERT</i> gene variant as the cause of pleuroparenchymal fibroelastosisJulian Pott, Ann-Sophie Höing, Alexander Volk, et al.
Lung|May 1, 2015
Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial HypertensionJasmin Wellbrock, Lars Harbaum, Hauke Stamm, et al.
Virchows Archiv : an International Journal of Pathology|June 15, 2016
MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significanceJohannes Betge, Nora I Schneider, Lars Harbaum, et al.
BMC Pulmonary Medicine|April 28, 2017
Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertensionLars Harbaum, Kaaja M Baaske, Marcel Simon, et al.
Pneumologie (Stuttgart, Germany)|November 14, 2023
[Targeted therapy for pulmonary arterial hypertension in patients without comorbidities]Hans Klose, Lars Harbaum, Manuel J Richter, et al.
Pageof 7